Gotimmune Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Gotimmune General Information

Description

Developer of therapeutic products. The company develops therapeutics products that aid in the treatment of Helicobacter pylori.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Erik Dahlbergsgatan 11A
  • floor 2
  • 411 26 Gothenburg
  • Sweden
+46 070-713 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gotimmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Gotimmune’s complete valuation and funding history, request access »

Gotimmune Executive Team (2)

Name Title Board Seat Contact Info
Jan Holmgren Co-Founder
Nils Lycke Ph.D Co-Founder
To view Gotimmune’s complete executive team members history, request access »

Gotimmune Board Members (1)

Name Representing Role Since
Klementina Österberg GU Ventures Chairman 000 0000
To view Gotimmune’s complete board members history, request access »

Gotimmune Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GU Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view Gotimmune’s complete investors history, request access »